These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: No significant association between the genetic polymorphisms in the GSK-3 beta gene and schizophrenia in the Chinese population.
    Author: Meng J, Shi Y, Zhao X, Zhou J, Zheng Y, Tang R, Ma G, Zhu X, He Z, Wang Z, Xu Y, Feng G, He L.
    Journal: J Psychiatr Res; 2008 Apr; 42(5):365-70. PubMed ID: 17368486.
    Abstract:
    The GSK-3 beta gene encodes a protein kinase which is abundant in the brain, and its product is involved in signal transduction cascades of neuronal cell development, energy metabolism and body pattern formation. Previous studies have suggested that GSK-3 beta might act as a potential candidate locus for schizophrenia susceptibility. We genotyped six SNPs within the gene and conducted a case-control study involving 329 schizophrenic patients and 288 healthy subjects in the Chinese population. We examined allele and genotype frequencies and haplotype distributions in the subtype of paranoid schizophrenic patients as well as schizophrenic subjects in general. Our results fail to replicate the association of the GSK-3 beta gene with susceptibility to schizophrenia in the Chinese population.
    [Abstract] [Full Text] [Related] [New Search]